CLEVELAND BIOLABS INC Note Agreements
4 Contracts & Agreements
- Amended and Restated Convertible Note Due May 1, 2024, dated as of November 7, 2022 (Filed With SEC on November 15, 2022)
- Assignment of Promissory Note, dated November 7, 2022, by and among Avenue Venture Opportunities Fund, L.P., Silverback Capital Corporation and Statera Biopharma, Inc (Filed With SEC on November 15, 2022)
- Amended and Restated Convertible Note Due May 1, 2024, dated as of October 18, 2022 (Filed With SEC on October 24, 2022)
- Assignment of Promissory Note, dated October 18, 2022, by and among Avenue Venture Opportunities Fund, L.P., Silverback Capital Corporation and Statera Biopharma, Inc (Filed With SEC on October 24, 2022)
